+831.1%
MRNA vs LSCC
+83.2%
+747.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LSCC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +10.4% | -11.2% | -2.0% |
| 7D | -3.8% | +14.5% | -18.2% | -5.3% |
| 30D | +16.4% | -0.1% | +16.4% | +14.7% |
| 3M | +310.6% | -2.7% | +313.2% | +305.8% |
| 6M | +370.3% | -4.8% | +375.1% | +354.0% |
| YTD | +743.3% | +66.9% | +676.5% | +481.3% |
| All | +831.1% | +83.2% | +747.9% | +468.9% |
Cumulative growth
Daily Returns
Daily percentage return beside LSCC.
Daily Out/Under-Performance
Portfolio return minus LSCC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LSCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LSCC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling